Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Jan 03, 2024 |
referred to higher education |
May 09, 2023 |
referred to higher education |
Assembly Bill A6988
2023-2024 Legislative Session
Sponsored By
JACOBSON
Current Bill Status - In Assembly Committee
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
2023-A6988 (ACTIVE) - Details
2023-A6988 (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 6988 2023-2024 Regular Sessions I N A S S E M B L Y May 9, 2023 ___________ Introduced by M. of A. JACOBSON -- read once and referred to the Commit- tee on Higher Education AN ACT to amend the education law, in relation to the substitution of brand name epinephrine auto-injectors with alternate epinephrine auto- injectors for dispensation by pharmacists THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Section 6816-a of the education law is amended by adding a new subdivision 6 to read as follows: 6. (A) NOTWITHSTANDING SUBDIVISION TWO OF THIS SECTION OR ANY OTHER SECTION OF LAW TO THE CONTRARY, WHEN A PATIENT IS PRESCRIBED A BRAND NAME EPINEPHRINE AUTO-INJECTOR, A PHARMACIST MAY SUBSTITUTE AN ALTERNATE EPINEPHRINE AUTO-INJECTOR CONTAINING THE SAME ACTIVE INGREDIENTS, DOSAGE FORM AND STRENGTH AS THE BRAND NAME PRODUCT PRESCRIBED, ORDERED OR DEMANDED, REGARDLESS OF WHETHER THE ALTERNATE EPINEPHRINE AUTO-INJECTOR IS INCLUDED IN THE LATEST LIST OF INTERCHANGEABLE DRUG PRODUCTS FOR THE PRESCRIBED EPINEPHRINE AUTO-INJECTOR DEVICE, PROVIDED THAT: (I) THE PRESCRIBER DOES NOT INDICATE THAT THE PRESCRIPTION THEREFOR SHALL BE DISPENSED AS WRITTEN PURSUANT TO PARAGRAPH (A) OF SUBDIVISION SIX OF SECTION SIXTY-EIGHT HUNDRED TEN OF THIS ARTICLE; (II) THE ALTERNATE EPINEPHRINE AUTO-INJECTOR AVAILABLE WOULD REFLECT A LOWER UNIT COST TO THE PURCHASER; (III) THE PHARMACIST HAS ADVISED THE PURCHASER OF THE AVAILABILITY OF AN ALTERNATE EPINEPHRINE AUTO-INJECTOR AND OBTAINED CONSENT TO DISPENSE THE ALTERNATE EPINEPHRINE AUTO-INJECTOR; AND (IV) THE PHARMACIST HAS COUNSELED THE PATIENT OR PERSON AUTHORIZED TO ACT ON THE PATIENT'S BEHALF ON THE PROPER USAGE AND OPERATING FEATURES OF THE ALTERNATE EPINEPHRINE AUTO-INJECTOR. (B) FOR PURPOSES OF THIS SUBDIVISION "EPINEPHRINE AUTO-INJECTOR" SHALL HAVE THE SAME MEANING AS PROVIDED IN PARAGRAPH (B) OF SUBDIVISION ONE OF SECTION THREE THOUSAND-C OF THE PUBLIC HEALTH LAW. § 2. This act shall take effect immediately. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted.
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.